ZVRA FY 2025 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$618M

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$106M+350.9% YoY

Gross Profit

$90M84.5% margin

Operating Income

-$63M-59.1% margin

Net Income

$83M78.2% margin

EPS (Diluted)

$1.35

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$285M

Total Liabilities

$130M

Stockholders' Equity

$155M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$106M	$24M	+350.9%
Gross Profit	$90M	$16M	+455.7%
Operating Income	-$63M	-$87M	+27.7%
Net Income	$83M	-$106M	+178.9%